Christos V. Rizos

2.2k total citations
42 papers, 1.3k citations indexed

About

Christos V. Rizos is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Christos V. Rizos has authored 42 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Surgery, 20 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Molecular Biology. Recurrent topics in Christos V. Rizos's work include Lipoproteins and Cardiovascular Health (23 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (13 papers) and Cancer, Lipids, and Metabolism (7 papers). Christos V. Rizos is often cited by papers focused on Lipoproteins and Cardiovascular Health (23 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (13 papers) and Cancer, Lipids, and Metabolism (7 papers). Christos V. Rizos collaborates with scholars based in Greece, United Kingdom and United States. Christos V. Rizos's co-authors include Moses Elisaf, Evangelos Liberopoulos, D.P. Mikhailidis, Theodosios D. Filippatos, Anastazia Kei, Michael S. Kostapanos, Alexandros D. Tselepis, Matilda Florentin, Aris P. Agouridis and Konstantinos Lagos and has published in prestigious journals such as European Journal of Pharmacology, Atherosclerosis and Current Pharmaceutical Design.

In The Last Decade

Christos V. Rizos

42 papers receiving 1.2k citations

Peers

Countries citing papers authored by Christos V. Rizos

Since Specialization

Citations

This map shows the geographic impact of Christos V. Rizos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christos V. Rizos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christos V. Rizos more than expected).

Fields of papers citing papers by Christos V. Rizos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christos V. Rizos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christos V. Rizos. The network helps show where Christos V. Rizos may publish in the future.

Co-authorship network of co-authors of Christos V. Rizos

This figure shows the co-authorship network connecting the top 25 collaborators of Christos V. Rizos. A scholar is included among the top collaborators of Christos V. Rizos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christos V. Rizos. Christos V. Rizos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Emerging Fixed-Dose Combination Treatments for Hyperlipidemia 2019 ·Journal of Cardiovascular Pharmacology and Therapeutics ·(unknown), Christos V. Rizos, Theodosios D. Filippatos, Moses Elisaf	10
2	Characteristics and management of 1093 patients with clinical diagnosis of familial hypercholesterolemia in Greece: Data from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH) 2018 ·Atherosclerosis ·Christos V. Rizos, Moses Elisaf, Ioannis Skoumas, Κωνσταντίνος Τζιόμαλος, Vasilios Kotsis, Lοukianos S. Rallidis, Anastasia Garoufi, Vasilios G. Athyros, Emmanouil Skalidis, Genovefa Kolovou, Iosif Koutagiar, Marianthi Papagianni, Christina Antza, Niki Katsiki, Emmanuel S. Ganotakis, Evangelos Liberopoulos	17
3	An insight into familial hypercholesterolemia in Greece: rationale and design of the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH) 2017 ·HORMONES ·Christos V. Rizos, Vasilios G. Athyros, E. Bilianou, George P. Chrousos, Anastasia Garoufi, Genovefa Kolovou, Vasilios Kotsis, Lοukianos S. Rallidis, (unknown), (unknown), Κωνσταντίνος Τζιόμαλος, Evangelos Liberopoulos	1
4	Pharmacokinetic drug evaluation of empagliflozin plus linagliptin for the treatment of type 2 diabetes 2017 ·Expert Opinion on Drug Metabolism & Toxicology ·Christos V. Rizos, Theodosios D. Filippatos, Moses Elisaf	6
5	Effects of PCSK9 Inhibitors on Other than Low-Density Lipoprotein Cholesterol Lipid Variables 2017 ·Journal of Cardiovascular Pharmacology and Therapeutics ·Theodosios D. Filippatos, Anastazia Kei, Christos V. Rizos, Moses Elisaf	33
6	Acid-base and electrolyte disorders associated with the use of antidiabetic drugs 2017 ·Expert Opinion on Drug Safety ·Theodosios D. Filippatos, (unknown), Christos V. Rizos, Moses Elisaf, Georgé Liamis	22
7	The current role of thiazolidinediones in diabetes management 2016 ·Archives of Toxicology ·Christos V. Rizos, Anastazia Kei, Moses Elisaf	54
8	Benefit–Risk Assessment of Rosuvastatin in the Treatment of Atherosclerosis and Related Diseases 2014 ·Drug Safety ·Michael S. Kostapanos, Christos V. Rizos, Moses Elisaf	7
9	Does Combination Therapy with Statins and Fibrates Prevent Cardiovascular Disease in Diabetic Patients with Atherogenic Mixed Dyslipidemia? 2013 ·The Review of Diabetic Studies ·Aris P. Agouridis, Christos V. Rizos, Moses Elisaf, Theodosios D. Filippatos	31
10	Metformin and cancer 2013 ·European Journal of Pharmacology ·Christos V. Rizos, Moses Elisaf	128
11	Colesevelam Plus Rosuvastatin 5 mg/Day Versus Rosuvastatin 10 mg/Day Alone on Markers of Insulin Resistance in Patients with Hypercholesterolemia and Impaired Fasting Glucose 2012 ·Metabolic Syndrome and Related Disorders ·Matilda Florentin, Evangelos Liberopoulos, Christos V. Rizos, Anastazia Kei, Georgé Liamis, Michael S. Kostapanos, Moses Elisaf	12
12	The effect of simvastatin alone versus simvastatin plus ezetimibe on the concentration of small dense low-density lipoprotein cholesterol in subjects with primary hypercholesterolemia 2011 ·Current Medical Research and Opinion ·Matilda Florentin, Evangelos Liberopoulos, Elisavet Moutzouri, Christos V. Rizos, Alexandros D. Tselepis, Moses Elisaf	23
13	Combining Rosuvastatin with Sartans of Different Peroxisome Proliferator-Activated Receptor-γ Activating Capacity Is Not Associated with Different Changes in Low-Density Lipoprotein Subfractions and Plasma Lipoprotein-Associated Phospholipase A ₂ 2011 ·Metabolic Syndrome and Related Disorders ·Christos V. Rizos, Evangelos Liberopoulos, Constantinos C. Tellis, Matilda Florentin, Moses Elisaf, Alexandros D. Tselepis	4
14	Effect of Non-Statin Lipid Lowering and Anti-Obesity Drugs on LDL Subfractions in Patients with Mixed Dyslipidaemia 2010 ·Current Vascular Pharmacology ·Matilda Florentin, (unknown), Moses Elisaf, Christos V. Rizos, Dimitri P. Mikhailidis, Evangelos Liberopoulos	25
15	Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: A 24-week, randomized, open-label, prospective study 2010 ·Clinical Therapeutics ·Christos V. Rizos, Haralampos Milionis, Michael S. Kostapanos, Matilda Florentin, Christina Kostara, Moses Elisaf, Evangelos Liberopoulos	38
16	Rosuvastatin treatment is associated with an increase in insulin resistance in hyperlipidaemic patients with impaired fasting glucose 2009 ·International Journal of Clinical Practice ·Michael S. Kostapanos, Haralambos Milionis, Aris P. Agouridis, Christos V. Rizos, Moses Elisaf	37
17	Are the Pleiotropic Effects of Telmisartan Clinically Relevant? 2009 ·Current Pharmaceutical Design ·Christos V. Rizos, Moses Elisaf, Evangelos Liberopoulos	16
18	How safe is the use of thiazolidinediones in clinical practice? 2008 ·Expert Opinion on Drug Safety ·Christos V. Rizos, Moses Elisaf, D.P. Mikhailidis, Evangelos Liberopoulos	134
19	HCV-RNA qualitative assay based on transcription mediated amplification improves the detection of hepatitis C virus infection in patients on hemodialysis: Results from five hemodialysis units in central Greece 2005 ·Journal of Clinical Virology ·Eirini I. Rigopoulou, Ioannis Stefanidis, Christos Liaskos, Eleftheria Zervou, Christos V. Rizos, (unknown), Kalliopi Zachou, (unknown), (unknown), George Kyriakopoulos, (unknown), (unknown), George Ν. Dalekos	33
20	Encephalocraniocutaneous lipomatosis accompanied by maxillary compound odontoma and juvenile angiofibroma: Report of a case 2004 ·Birth Defects Research Part A Clinical and Molecular Teratology ·(unknown), Christos V. Rizos, Maria Belazi, (unknown), D. Antoniades	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact